These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 30665924)

  • 1. Trimethylamine
    Stubbs JR; Stedman MR; Liu S; Long J; Franchetti Y; West RE; Prokopienko AJ; Mahnken JD; Chertow GM; Nolin TD
    Clin J Am Soc Nephrol; 2019 Feb; 14(2):261-267. PubMed ID: 30665924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood Calcification Propensity, Cardiovascular Events, and Survival in Patients Receiving Hemodialysis in the EVOLVE Trial.
    Pasch A; Block GA; Bachtler M; Smith ER; Jahnen-Dechent W; Arampatzis S; Chertow GM; Parfrey P; Ma X; Floege J
    Clin J Am Soc Nephrol; 2017 Feb; 12(2):315-322. PubMed ID: 27940458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of Trimethylamine N-Oxide With Nutritional and Inflammatory Biomarkers and Cardiovascular Outcomes in Patients New to Dialysis.
    Kaysen GA; Johansen KL; Chertow GM; Dalrymple LS; Kornak J; Grimes B; Dwyer T; Chassy AW; Fiehn O
    J Ren Nutr; 2015 Jul; 25(4):351-6. PubMed ID: 25802017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effects of Cinacalcet in Older and Younger Patients on Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial.
    Parfrey PS; Drüeke TB; Block GA; Correa-Rotter R; Floege J; Herzog CA; London GM; Mahaffey KW; Moe SM; Wheeler DC; Kubo Y; Dehmel B; Goodman WG; Chertow GM;
    Clin J Am Soc Nephrol; 2015 May; 10(5):791-9. PubMed ID: 25710802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trimethylamine-
    Zheng Y; Tang Z; You L; Wu Y; Liu J; Xue J
    Ren Fail; 2020 Nov; 42(1):580-586. PubMed ID: 32576072
    [No Abstract]   [Full Text] [Related]  

  • 6. Association of trimethylamine
    Zhang P; Zou JZ; Chen J; Tan X; Xiang FF; Shen B; Hu JC; Wang JL; Wang YQ; Yu JB; Nie YX; Chen XH; Yu JW; Zhang Z; Lv WL; Xie YQ; Cao XS; Ding XQ
    Ren Fail; 2020 Nov; 42(1):1004-1014. PubMed ID: 32985309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cinacalcet on atherosclerotic and nonatherosclerotic cardiovascular events in patients receiving hemodialysis: the EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) trial.
    Wheeler DC; London GM; Parfrey PS; Block GA; Correa-Rotter R; Dehmel B; Drüeke TB; Floege J; Kubo Y; Mahaffey KW; Goodman WG; Moe SM; Trotman ML; Abdalla S; Chertow GM; Herzog CA;
    J Am Heart Assoc; 2014 Nov; 3(6):e001363. PubMed ID: 25404192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Effectiveness of Calcimimetic Agents for Secondary Hyperparathyroidism in Adults: A Systematic Review and Network Meta-analysis.
    Palmer SC; Mavridis D; Johnson DW; Tonelli M; Ruospo M; Strippoli GFM
    Am J Kidney Dis; 2020 Sep; 76(3):321-330. PubMed ID: 32475604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut Microbiota-Dependent Trimethylamine N-oxide and Cardiovascular Outcomes in Patients With Prior Myocardial Infarction: A Nested Case Control Study From the PEGASUS-TIMI 54 Trial.
    Gencer B; Li XS; Gurmu Y; Bonaca MP; Morrow DA; Cohen M; Bhatt DL; Steg PG; Storey RF; Johanson P; Wang Z; Hazen SL; Sabatine MS
    J Am Heart Assoc; 2020 May; 9(10):e015331. PubMed ID: 32366163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of Plasma Concentration of Trimethylamine N-Oxide in Predicting Cardiovascular and Renal Complications in Individuals With Type 1 Diabetes.
    Winther SA; Øllgaard JC; Tofte N; Tarnow L; Wang Z; Ahluwalia TS; Jorsal A; Theilade S; Parving HH; Hansen TW; Hazen SL; Pedersen O; Rossing P
    Diabetes Care; 2019 Aug; 42(8):1512-1520. PubMed ID: 31123156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline characteristics of subjects enrolled in the Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) trial.
    Chertow GM; Correa-Rotter R; Block GA; Drueke TB; Floege J; Goodman WG; Herzog CA; Kubo Y; London GM; Mahaffey KW; Mix TC; Moe SM; Wheeler DC; Parfrey PS
    Nephrol Dial Transplant; 2012 Jul; 27(7):2872-9. PubMed ID: 22529163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis.
    ; Chertow GM; Block GA; Correa-Rotter R; Drüeke TB; Floege J; Goodman WG; Herzog CA; Kubo Y; London GM; Mahaffey KW; Mix TC; Moe SM; Trotman ML; Wheeler DC; Parfrey PS
    N Engl J Med; 2012 Dec; 367(26):2482-94. PubMed ID: 23121374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: A Randomized Clinical Trial.
    Block GA; Bushinsky DA; Cheng S; Cunningham J; Dehmel B; Drueke TB; Ketteler M; Kewalramani R; Martin KJ; Moe SM; Patel UD; Silver J; Sun Y; Wang H; Chertow GM
    JAMA; 2017 Jan; 317(2):156-164. PubMed ID: 28097356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effectiveness of cinacalcet: a randomized, open label study in chronic hemodialysis patients with severe secondary hyperparathyroidism.
    Susantitaphong P; Vadcharavivad S; Susomboon T; Singhan W; Dumrongpisutikul N; Jakchairoongruang K; Eiam-Ong S; Praditpornsilpa K
    Ren Fail; 2019 Nov; 41(1):326-333. PubMed ID: 31014177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The win ratio approach to analyzing composite outcomes: An application to the EVOLVE trial.
    Abdalla S; Montez-Rath ME; Parfrey PS; Chertow GM
    Contemp Clin Trials; 2016 May; 48():119-24. PubMed ID: 27080930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality in dialysis patients with cinacalcet use: A large observational registry study.
    Friedl C; Reibnegger G; Kramar R; Zitt E; Pilz S; Mann JFE; Rosenkranz AR
    Eur J Intern Med; 2017 Jul; 42():89-95. PubMed ID: 28499709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Trimethylamine N-oxide and Adverse Kidney Outcomes and Overall Mortality in Type 2 Diabetes Mellitus.
    Yu PS; Wu PH; Hung WW; Lin MY; Zhen YY; Hung WC; Chang JM; Tsai JR; Chiu YW; Hwang SJ; Tsai YC
    J Clin Endocrinol Metab; 2024 Jul; 109(8):2097-2105. PubMed ID: 38267025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of cinacalcet on blood pressure, mortality and cardiovascular endpoints in the EVOLVE trial.
    Chang TI; Abdalla S; London GM; Block GA; Correa-Rotter R; Drüeke TB; Floege J; Herzog CA; Mahaffey KW; Moe SM; Parfrey PS; Wheeler DC; Dehmel B; Goodman WG; Chertow GM
    J Hum Hypertens; 2016 Mar; 30(3):204-9. PubMed ID: 26040438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trimethylamine N-Oxide and Cardiovascular Events in Hemodialysis Patients.
    Shafi T; Powe NR; Meyer TW; Hwang S; Hai X; Melamed ML; Banerjee T; Coresh J; Hostetter TH
    J Am Soc Nephrol; 2017 Jan; 28(1):321-331. PubMed ID: 27436853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interventions for lowering plasma homocysteine levels in dialysis patients.
    Nigwekar SU; Kang A; Zoungas S; Cass A; Gallagher MP; Kulshrestha S; Navaneethan SD; Perkovic V; Strippoli GF; Jardine MJ
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD004683. PubMed ID: 27243372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.